Overview
Binds to formyl peptide receptors on immune cells and directly disrupts pathogen cell membranes.
Proposed mechanism
LL-37 is a cathelicidin-derived antimicrobial peptide that disrupts microbial membranes and modulates chemokine production in respiratory epithelium.
What the evidence supports
Evidence rests primarily on self-reported experience. Controlled studies are lacking.
Graded Anecdotal
Case reports, clinician notes, and user-reported outcomes. Recorded for completeness and labelled plainly so it is never mistaken for data.
Key citations
Representative primary sources, including results that did not favour the compound.
- [1]
LL-37 in respiratory infection
· DOI:10.1164/rccm.201708-1621OC · 2018
- [2]
Cathelicidin in lung health
· DOI:10.1038/nri2435 · 2008
- [3]
LL-37 in respiratory infection (2018)
· · 0
- [4]
Cathelicidin in lung health (2008)
· · 0
Citation records in this build are illustrative placeholders for the design.
Reference information for research purposes. Not medical advice, and not a recommendation to use any compound. Many entries describe substances that are not approved for human use.